Equity Research
William Blair research analyst Margaret Kaczor was quoted in CNBC’s coverage of Abbott Laboratories’ presentation at the global health conference HLTH, where the biotech giant’s CEO discussed differentiating revenue streams following a decline in COVID-19 testing kits, among other factors.
Of the major revenue opportunities Kaczor flagged in previous conversations with the publication is Abbott’s share of the continuous glucose monitor market globally.
Stay up-to-date with the latest William Blair news and insights
Jed Dorsheimer welcomes Doomberg for an in-depth discussion on the complexities of renewable energy integration and its impact on grid efficiency, exploring the challenges posed by the variability of renewables, the resurgence of nuclear power, and the critical role of natural gas in bridging the energy transition.
William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, is thrilled to announce its performance in the annual Coalition Greenwich Voice of the Client – 2024 North American Equity Investors Study.
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures
